# Sonja Levy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sonja-levy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 239 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 8 |
| i10-index | 8 |
| Last Known Institution | The Netherlands Cancer Institute |
| OpenAlex ID | https://openalex.org/A5063932360 |
| ORCID iD | 0000-0001-9457-2074 |
| Works | 21 |

## Researcher papers

- [Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites](https://scholariq.org/papers/druggable-growth-dependencies-and-tumor-evolution-analysis-in-patient-derived/)
- [Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort](https://scholariq.org/papers/avelumab-for-advanced-merkel-cell-carcinoma-in-the-netherlands-a-real-world/)
- [Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours](https://scholariq.org/papers/driver-mutations-occur-frequently-in-metastases-of-well-differentiated-small/)
- [Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival](https://scholariq.org/papers/survival-in-patients-with-neuroendocrine-tumours-of-the-small-intestine-nomogram/)
- [Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT–confirmed complete response](https://scholariq.org/papers/avelumab-treatment-for-patients-with-metastatic-merkel-cell-carcinoma-can-be/)
- [Well-Differentiated Bronchopulmonary Neuroendocrine Tumors: More Than One Entity](https://scholariq.org/papers/well-differentiated-bronchopulmonary-neuroendocrine-tumors-more-than-one-entity/)
- [Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study](https://scholariq.org/papers/elevated-serotonin-and-nt-probnp-levels-predict-and-detect-carcinoid-heart/)
- [First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial](https://scholariq.org/papers/first-line-everolimus-and-cisplatin-in-patients-with-advanced-extrapulmonary/)
- [Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers](https://scholariq.org/papers/primary-tumor-resection-is-associated-with-improved-disease-specific-mortality/)
- [Postoperative radiotherapy in stage I–III Merkel cell carcinoma](https://scholariq.org/papers/postoperative-radiotherapy-in-stage-i-iii-merkel-cell-carcinoma/)
- [Four decades of experience with carcinoid heart disease: An analysis of 84 patients](https://scholariq.org/papers/four-decades-of-experience-with-carcinoid-heart-disease-an-analysis-of-84/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Bacteriophages and microbial interactions](https://scholariq.org/topics/bacteriophages-and-microbial-interactions/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)

## Researcher university

- [The Netherlands Cancer Institute](https://scholariq.org/institutions/the-netherlands-cancer-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.